- Home
- GAB vs BCRX Comparison
GAB vs BCRX Comparison
Compare GAB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAB
- BCRX
- Stock Information
- Founded
- GAB 1986
- BCRX 1986
- Country
- GAB United States
- BCRX United States
- Employees
- GAB N/A
- BCRX N/A
- Industry
- GAB Investment Managers
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAB Finance
- BCRX Health Care
- Exchange
- GAB Nasdaq
- BCRX Nasdaq
- Market Cap
- GAB 1.9B
- BCRX 1.5B
- IPO Year
- GAB N/A
- BCRX 1994
- Fundamental
- Price
- GAB $5.93
- BCRX $6.63
- Analyst Decision
- GAB
- BCRX Strong Buy
- Analyst Count
- GAB 0
- BCRX 11
- Target Price
- GAB N/A
- BCRX $19.55
- AVG Volume (30 Days)
- GAB 667.8K
- BCRX 6.0M
- Earning Date
- GAB 01-01-0001
- BCRX 11-03-2025
- Dividend Yield
- GAB 10.91%
- BCRX N/A
- EPS Growth
- GAB N/A
- BCRX N/A
- EPS
- GAB N/A
- BCRX N/A
- Revenue
- GAB N/A
- BCRX $557,506,000.00
- Revenue This Year
- GAB N/A
- BCRX $41.40
- Revenue Next Year
- GAB N/A
- BCRX $5.33
- P/E Ratio
- GAB N/A
- BCRX N/A
- Revenue Growth
- GAB N/A
- BCRX 45.85
- 52 Week Low
- GAB $4.56
- BCRX $6.00
- 52 Week High
- GAB $5.88
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- GAB 39.19
- BCRX 32.24
- Support Level
- GAB $5.87
- BCRX $6.00
- Resistance Level
- GAB $6.05
- BCRX $6.92
- Average True Range (ATR)
- GAB 0.08
- BCRX 0.29
- MACD
- GAB -0.02
- BCRX -0.04
- Stochastic Oscillator
- GAB 19.05
- BCRX 36.22
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.